Biobanking and Pharmacogenomics
- 23 April 2010
- journal article
- review article
- Published by Informa UK Limited in Pharmacogenomics
- Vol. 11 (5), 637-641
- https://doi.org/10.2217/pgs.10.13
Abstract
The study of genetic determinants underlying drug outcome is rapidly advancing. Initial success was realized within the context of candidate pharmacokinetic genes and serious adverse drug reactions, particularly for drugs with narrow therapeutic indices. Although genetic predictors of outcome have proven useful in other contexts, effect size has typically been small. To address these challenges, the clinical and scientific communities have begun studying larger numbers of gene variants (often at the genome-wide level) in cohorts of increasing sample size. Electronic health records are being increasingly used for this purpose. Longitudinal data available in practice-based datasets will position investigators to characterize genetic factors with small but reproducible effects on drug outcome in the context of gene-environment interactions.Keywords
Funding Information
- National Human Genome Research Institute (1U01HG004608)
- National Heart Lung and Blood and Sleep Institute (U01HL069757)
This publication has 21 references indexed in Scilit:
- Current Understanding of the Pharmacogenomics of MetforminClinical Pharmacology & Therapeutics, 2009
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinNature Genetics, 2009
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Identifying genetic risk factors for serious adverse drug reactions: current progress and challengesNature Reviews Drug Discovery, 2007
- Combinatorial PharmacogeneticsNature Reviews Drug Discovery, 2005
- Cytochrome P450 Gene-Based Drug Prescribing and Factors Impacting Translation into Routine Clinical PracticePersonalized Medicine, 2005
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseNew England Journal of Medicine, 2005
- Marshfield Clinic Personalized Medicine Research Project (PMRP): Design, Methods and Recruitment for a Large Population-Based BiobankPersonalized Medicine, 2005
- Informed Consent in PharmacogenomicsThe Pharmacogenomics Journal, 2002
- Dusting off recombinant allergensNature Biotechnology, 1997